Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CHAMPIONS ONCOLOGY, INC. Director's Dealing 2015

Jan 13, 2015

10828_dirs_2015-01-13_f3723f8f-36fb-40d6-ad85-f2ab861076ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK: 0000771856
Period of Report: 2014-12-01

Reporting Person: Morris Ronnie (Director, President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-01 Convertible Promissory Note $ A Acquired Common Stock () Direct

Footnotes

F1: The convertible promissory note has a term of 90 days. The note, including any accrued but unpaid interest, is convertible at the option of the noteholder: (a) upon the closing of any equity financing that occurs during the term of the note, into the securities offered in the financing to other investors at a 5% discount to the price per share paid by other investors in the financing; and (b) upon the maturity date of the note, into the Company's common stock at the volume weighted average closing price of the common stock for the five trading days prior to such conversion.